|

sirolimus (albumin-bound) Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1/2: 1

Top Sponsors

  • Fudan University1
  • CSPC ZhongQi Pharmaceutical Technology Co., Ltd.1

Indications

  • Cancer2
  • Resistant to (Neo)Adjuvant Endocrine Therapy1
  • Advanced HR - Positive, HER2 - Negative Breast Cancer1
  • Advanced Solid Tumors1
  • Breast Cancer1

Other2 trials

A Study of Sirolimus (Albumin-Bound) in Combination With Different ADCs Treatment of Advanced Solid Tumors
Phase 1/2
A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.